Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition
NMS Group
May 17, 2021

Nerviano, 17 May 2021  The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years.

Our specializations, preclinical and early phase clinical development respectively, our shared values and expertise led us now to start a common project: to offer our clients an integrated solution aimed to streamline and optimize the clinical development process in the critical moment of the transition from pre-clinical to clinical set up.

We invite you to have a look to our informative material below in which we have listed the benefits of this package, product of the synergy of two healthy and stable companies.

 

link to PDF Accelera and CROSS: an integrated solution

 

Welcome and Check out our new motion picture!

WATCH OUR VIDEO